Press release - 12/05/2009 Gene variant responsible for defective communication in the brain Schizophrenia and bipolar disorder are psychological diseases that are both common and severe. The causes of these diseases are largely unknown. It has been known for some time that certain hereditary factors enhance the risk of developing schizophrenia or a manic-depressive disorder. Researchers from the ZI in Mannheim and the Department of Medicine Psychology at the University of Bonn have managed to identify the effects of such gene variants…https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-variant-responsible-for-defective-communication-in-the-brain
Article - 12/05/2009 Fatal relatives: adiposity and diabetes Martin Wabitsch was the first German pediatrician to investigate adiposity back when it was seen as a strange subject to study. Nowadays, in Germany the attitude towards adiposity has completely changed. More and more people are suffering from adiposity and diabetes and are consequently at risk of contracting other severe diseases as a result. In children and young adults the situation is alarming; many children are at risk of contracting…https://www.gesundheitsindustrie-bw.de/en/article/news/fatal-relatives-adiposity-and-diabetes
Article - 11/05/2009 Can stem cells treat diabetes? Stem cells are seen as the miracle cure of the future for many degenerative diseases. Scientists and physicians also hope that stem cells will exert their regenerative effect in the treatment of diabetes type 1 which is caused by damaged tissue. https://www.gesundheitsindustrie-bw.de/en/article/news/can-stem-cells-treat-diabetes
Dossier - 11/05/2009 Diabetes, a danger that is still underestimated In 2010 there will be 10 million diabetes patients in Germany and nearly 33 millions in Europe. The diabetes avalanche is rolling and what is Germany doing? So far so little say experts. There is a lot happening at the same time in different places little is evaluated and a lot is lost in the maelstrom of individual interests. The figures are clear The metabolic disease known as diabetes has reached the proportions of a worldwide epidemic. It not…https://www.gesundheitsindustrie-bw.de/en/article/dossier/diabetes-a-danger-that-is-still-underestimated
Article - 04/05/2009 Perikles Simon – more than just hunting down the dope cheats Whether it be the Olympic Games world championships or the Tour de France whenever a big sports event is coming up Dr. Dr. Perikles Simon from the University Hospital of Tübingen is a sought-after interviewee for the media. Simon has developed a test which may eventually help detect the latest performance-enhancing method gene doping.https://www.gesundheitsindustrie-bw.de/en/article/news/perikles-simon-more-than-just-hunting-down-the-dope-cheats
Press release - 30/04/2009 Prize for more efficient radiotherapy for leukaemia Peter Kletting’s model can be used to irradiate the tumour cells of leukaemia patients more accurately, reduce potential side effects and increase the chances of therapeutic success. The scientist from the Department of Nuclear Medicine at the University Hospital of Ulm has been awarded the Society for Nuclear Medicine Covidien Award that comes with a purse of 7,500 euros. https://www.gesundheitsindustrie-bw.de/en/article/press-release/prize-for-more-efficient-radiotherapy-for-leukaemia
Press release - 29/04/2009 febit Receives European Patent for Gene Extraction Procedure febit holding gmbh announced today, that the company has been granted the first European patent (EP1436609) for a microarray-based nucleic acid extraction procedure. In conjunction with the US patent US7320862, febit now holds a unique patent position in the dynamic market of sample preparation for second-generation sequencers. https://www.gesundheitsindustrie-bw.de/en/article/press-release/febit-receives-european-patent-for-gene-extraction-procedure
Article - 20/04/2009 Biomarkers for the identification of metastases Prof. Dr. Heike Allgayer a surgeon and molecular biologist from Heidelberg is investigating the molecular processes of the formation of tumour metastases. A major objective of her research is to find specific biomarkers that enable the early identification of metastases and to monitor the outcome of therapy. She has already received numerous prizes for her achievements.https://www.gesundheitsindustrie-bw.de/en/article/news/biomarkers-for-the-identification-of-metastases
Press release - 20/04/2009 Fluorescent cancer cells to guide brain surgeons Malignant brain tumours grow with fine extensions which make them hard to distinguish from healthy brain tissue during surgery. Scientists of the German Cancer Research Centre (Deutsches Krebsforschungszentrum) and the University of Heidelberg have developed a staining method that makes tumour cells glow in yellow-green. Thus, borders between tumour tissue and normal tissue become visible during the entire operation, which makes resection easier…https://www.gesundheitsindustrie-bw.de/en/article/press-release/fluorescent-cancer-cells-to-guide-brain-surgeons
Press release - 20/04/2009 Help for coronary vessel constrictions – Tübingen cardiologists have developed an alternative to drug eluting stents Prof. Christian Herdeg at the University Hospital of Tübingen has developed an alternative approach for intracoronary pharmacotherapy for the treatment of patients with constricted coronary vessels. Localised drug delivery using special catheters is far superior to the use of uncoated stents and is also a way of avoiding the disadvantages of coated i.e. drug eluting stents. On 16th April 2009 the new method was awarded a prize at a meeting of the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/help-for-coronary-vessel-constrictions-tuebingen-cardiologists-have-developed-an-alternative-to-drug
Article - 20/04/2009 Anita Ignatius makes biomaterials smart Anita Ignatius is not interested in knowledge just for the sake of knowledge. “I have always been interested in the practical application of knowledge,” said the 45-year-old veterinarian. Highly theoretical courses she had to attend during her studies put an end to her dreams of opening her own practice after university. But this experience also had its advantages, because it helped her realise what she really wanted – namely doing research of…https://www.gesundheitsindustrie-bw.de/en/article/news/anita-ignatius-makes-biomaterials-smart
Press release - 17/04/2009 Who is pulling the threads in the cell? Cell division i.e. mitosis is key in the development of multicellular organisms be these dogs cats mice humans or plants. This process is controlled by specific proteins that interact closely with each other. Prof. Thomas U. Mayer a molecular geneticist at the University of Constance has gained new insights into the function of two of these proteins namely the CPC and Mklp2 proteins. He has discovered that a protein known as cyclin-dependent…https://www.gesundheitsindustrie-bw.de/en/article/press-release/who-is-pulling-the-threads-in-the-cell
Article - 07/04/2009 Hendrik Küpper – at the service of plants and humans Prof. Hendrik Küpper had his first experience as a scientist in 1992 when together with his brother and a friend he participated in the German governments Jugend forscht contest. The students came first in biology in the national competition and first in both the Young Europeans Environmental Research Contest and the European Community Contest for Young Scientists. Back then Küpper was already interested in the interaction between heavy metals…https://www.gesundheitsindustrie-bw.de/en/article/news/hendrik-kuepper-at-the-service-of-plants-and-humans
Press release - 07/04/2009 What drove the cow mad? New insights into prion diseases For over twenty years scientists have known that a normal protein in the brain can become harmful and cause deadly illnesses such as Creutzfeld-Jakob disease CJD in humans and bovine spongiform encephalopathy BSE in cattle. What researchers have not been able to explain was why this natural prion protein PrP is produced by our bodies in the first place. A team of researchers at the University Constance have now shown that PrP plays a beneficial…https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-drove-the-cow-mad-new-insights-into-prion-diseases
Press release - 07/04/2009 Potential cause of severe form of Parkinson's disease discovered The causes of multiple system atrophy MSA a particularly severe form of Parkinsons disease have for a long time remained unknown. Researchers at the Hertie Institute for Clinical Brain Research in Tübingen have now shown that hereditary gene variants considerably increase the risk of contracting MSA. https://www.gesundheitsindustrie-bw.de/en/article/press-release/potential-cause-of-severe-form-of-parkinson-s-disease-discovered
Article - 06/04/2009 Frank Allgöwer: an engineer with wild ideas At the age of 19 Frank Allgöwer did not have the faintest idea that he would one day be head of the Department of Technical Cybernetics at the University of Stuttgart. There was no way he could have known this as the high-school graduate had never even heard of the subject. Neither could he have known that the methods developed in this department would one day be used to control robotic arms as well as to analyse biological processes. These days…https://www.gesundheitsindustrie-bw.de/en/article/news/frank-allgoewer-an-engineer-with-wild-ideas
Dossier - 29/03/2009 Options for the food industry Biotechnology has since found its way into the food industry and in fact into the entire value creation chain from raw material production to food processing to the sale of the final product. There are many ways in which biotechnology can contribute to better food products. These include the use of enzymes and microorganisms as well as in the production of food supplements and to improve analytic tests.https://www.gesundheitsindustrie-bw.de/en/article/dossier/options-for-the-food-industry
Press release - 26/03/2009 Sygnis Pharma AG increases capital SYGNIS Pharma AG reported its financial results for the first nine months of the fiscal year 20082009. The company improved its cash position significantly as a result of a successful capital increase. Following the capital increase the stake of dievini Hopp BioTech in SYGNIS Pharma AG increased to approximately 44.90 of the total share capital. The preparations for the phase II efficacy trial of its lead candidate AX200 in acute ischemic stroke…https://www.gesundheitsindustrie-bw.de/en/article/press-release/sygnis-pharma-ag-increases-capital
Article - 19/03/2009 BioTeSys: isolate, characterise, analyse Bioactive substances are the speciality of BioTeSys GmbH an Esslingen-based biotech company. The company works with a range of products including cosmetics plant and berry extracts and low-dosage non-prescription food supplements. BioTeSys investigates the efficacy of the active ingredients of such products as well as the raw materials used to manufacture them. https://www.gesundheitsindustrie-bw.de/en/article/news/biotesys-isolate-characterise-analyse
Article - 17/03/2009 Stefan Rotter – linking theory and experimentation in neurology Neurobiology and mathematics are two different worlds with two completely different languages. However the two disciplines have come together in research into the brain. While neurologists hope to unveil the brains secrets through measurements mathematicians are using formulas and theoretical models to describe brain functions. Stefan Rotter from the Bernstein Centre for Computational Neuroscience BCCN in Freiburg speaks the language of both…https://www.gesundheitsindustrie-bw.de/en/article/news/stefan-rotter-linking-theory-and-experimentation-in-neurology
Press release - 15/03/2009 Jürgen Wolfrum – crossing the frontiers of science The frontiers between scientific disciplines have always interested Prof. Jürgen Wolfrum a physicist who has been awarded many international prizes. Wolfrum is a pioneer in applied laser spectroscopy which he uses successfully in a variety of fields. For example in the automotive industry he uses laser spectroscopy to investigate elementary chemical reactions and combustion processes. https://www.gesundheitsindustrie-bw.de/en/article/press-release/juergen-wolfrum-crossing-the-frontiers-of-science
Press release - 12/03/2009 New strategy for the investigation of haematopoietic stem cells With the newly developed mouse model irradiation is no longer required. While the mutation in the growth factor receptor Kit KitWWv weakens the recipients stem cell compartment and makes room for the incoming donor cells the other two mutations are known to prevent rejection of donor haematopoietic stem cells by the recipients immune system. Thus these mice appear to accept all blood stem cells regardless of the mouse strain origin of the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-strategy-for-the-investigation-of-haematopoietic-stem-cells
Article - 05/03/2009 Christian Wirtz prefers a navigation system when operating on the brain One job but two workplaces Christian Rainer Wirtz has for some time now been commuting regularly along the Danube river between the Bavarian city of Günzburg and the Baden-Württemberg city of Ulm. The new medical director and professor for neurosurgery at the Ulm University Hospital runs a hospital on two sites i.e. the Günzburg District Hospital and the Safranberg Hospital in Ulm.https://www.gesundheitsindustrie-bw.de/en/article/news/christian-wirtz-prefers-a-navigation-system-when-operating-on-the-brain
Press release - 04/03/2009 Federal funding for new stem cell project at the ZRM Researchers in Tübingen have successfully cultivated germ cells of adult men to create pluripotent stem cells with a therapeutic potential similar to that of embryonic stem cells, but with much less potential for ethical conflict. Now, with funding from the German Federal Ministry of Education and Research, a new project has been launched to characterize these cells in depth and to explore their therapeutic application in regenerative medicine. https://www.gesundheitsindustrie-bw.de/en/article/press-release/federal-funding-for-new-stem-cell-project-at-the-zrm
Press release - 04/03/2009 Plant Pathogen Yields Substance to Fight Neuroblastoma Drug treatment of neuroblastoma, a tumor of the nervous system in children, poses major problems. Therefore, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been searching for substances that are suitable as a basis for developing better drugs. Now they have found a candidate: HC-toxin, which is isolated from a fungal plant pathogen. The substance from the maize pathogen reprograms neuroblastoma cells…https://www.gesundheitsindustrie-bw.de/en/article/press-release/plant-pathogen-yields-substance-to-fight-neuroblastoma